The DOI matches its Crossref record; 12 of the 14 references it cites were found in a registry or an index.
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
Open accessAbstract
Detection of asymptomatic or subclinical novel human coronavirus SARS-CoV-2 infection is critical for understanding the overall prevalence and infection potential of COVID-19. To estimate the cumulative prevalence of SARS-CoV-2 infection in China, we evaluated the host serologic response, measured by the levels of immunoglobulins M and G in 17,368 individuals, in the city of Wuhan, the epicenter of the COVID-19 pandemic in China, and geographic regions in the country, during the period from 9 March 2020 to 10 April 2020. In our cohorts, the seropositivity in Wuhan varied between 3.2% and 3.8% in different subcohorts. Seroposivity progressively decreased in other cities as the distance to the epicenter increased. Patients who visited a hospital for maintenance hemodialysis and healthcare workers also had a higher seroprevalence of 3.3% (51 of 1,542, 2.5-4.3%, 95% confidence interval (CI)) and 1.8% (81 of 4,384, 1.5-2.3%, 95% CI), respectively. More studies are needed to determine whether these results are generalizable to other populations and geographic locations, as well as to determine at what rate seroprevalence is increasing with the progress of the COVID-19 pandemic. Serologic surveillance has the potential to provide a more faithful cumulative viral attack rate for the first season of this novel SARS-CoV-2 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SARS-CoV-2 seroprevalence in our study is comparable with estimates from large population-based serosurveys in China, Switzerland, Spain, and the United States after the initial epidemic peak and after many tens of thousands of deaths (9, 10, 17, 18).”
From Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Self-citationSARS-CoV-2 Infection in Children
Lü, X., Zhang, L., Du, H. N., Zhang, J., Li, Y. Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005073 · Cited by 2,423
The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated Data
Turnbull, B. W. (1976) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.2517-6161.1976.tb01597.x · Cited by 1,835
Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1661-4 · Cited by 1,429
Self-citationA Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
Munster, V. J., Koopmans, M., van Doremalen, N., van Riel, D. A. J., & de Wit, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2000929 · Cited by 1,418
Cited by
Sorted by citations
Items 201–300 of 405
Gong, Q., Liu, S., Li, R., Yao, L., & Xiao, Z. (2021) · BMC Neurology · doi:10.1186/s12883-021-02216-6 · Cited by 10
Qu, L., Xie, C., Qiu, M., Yi, L., Liu, Z., Zou, L., Hu, P., Jiang, H., Lian, H., Yang, M., et al. (2024) · Viruses · doi:10.3390/v16040649 · Cited by 11
Self-citationNesbitt, D. J., Jin, D. K., Hogan, J. W., Yang, J., Chen, H., Chan, P. A., Simon, M. J., Vargas, M., King, E., Huard, R. C., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06438-4 · Cited by 9
Hamorsky, K. T., Bushau-Sprinkle, A. M., Kitterman, K. T., Corman, J. M., DeMarco, J. K., Keith, R. J., Bhatnagar, A., Fuqua, J. L., Lasnik, A. B., Joh, J. J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97423-z · Cited by 8
Hori, H., Fukuchi, T., Sanui, M., Moriya, T., & Sugawara, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257513 · Cited by 9
Liu, T., Hsiung, J., Zhao, S., Kost, J., Sreedhar, D., Olson, K., Keare, D., Roche, J., Hanson, C. V., Press, C. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.16.155580 · Cited by 9
Lau, C. S., Hoo, S. P., Liang, Y.-L., Phua, S. K., & Aw, T. C. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00201 · Cited by 9
Bułdak, R. J., Woźniak-Grygiel, E., Wąsik, M., Kasperczyk, J., Gawrylak-Dryja, E., Mond-Paszek, R., Konka, A., Badura-Brzoza, K., Fronczek, M., Golec, M., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084376 · Cited by 9
Özdemir, A., Çuha, M. D., Dizman, G. T., Alp, A., Metan, G., & Şener, B. (2021) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20219908 · Cited by 8
What can we learn from neonates with COVID-19?
Xiao, T., Yan, K., Wang, L.-S., & Zhou, W. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-020-00376-y · Cited by 8
Dietrich, M. L., Norton, E. B., Elliott, D. H., Smira, A. R., Raviv, O., Sasson, D. J., Monk, C. H., Michael, M. L., Rogers, N. P., Rouelle, J. A., et al. (2021) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2021.100047 · Cited by 8
Maior, C. B. S., Lins, I. D., Raupp, L. S., Moura, M. D. C., Felipe, F. C. D. B., Santana, J. M., Fernandes, M. P., Araújo, A. V., & Gomes, A. L. D. V. (2022) · Acta Tropica · doi:10.1016/j.actatropica.2022.106551 · Cited by 8
The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?
Li, X., Sridhar, S., & Chan, J. F. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000650 · Cited by 8
Seroprävalenz und SARS-CoV-2-Testung in Gesundheitsberufen
Ziemssen, F., Bayyoud, T., Bartz‐Schmidt, K. U., Peter, A., & Ueffing, M. (2020) · Der Ophthalmologe · doi:10.1007/s00347-020-01158-7 · Cited by 7
Mahdi, A., Khazen, G., Aziz, N., Mina, J., Papazian, A., Daou, L., Ahmar, J., Assaf, N., Abdulkhalek, A., Farhat, H. Z., et al. (2022) · IJID Regions · doi:10.1016/j.ijregi.2022.01.011 · Cited by 7
Monitoring the COVID-19 immune landscape in Japan
Sasanami, M., Kayano, T., & Nishiura, H. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.06.005 · Cited by 7
Iles, R. K., Iles, J. K., Zmuidinaite, R., & Roberts, M. (2022) · Viruses · doi:10.3390/v14091958 · Cited by 7
A versatile integrated tube for rapid and visual SARS-CoV-2 detection
Xu, J., Wang, X., Yang, S., He, L., Wang, Y., Li, J., Liu, Q., Li, M., & Wang, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1070831 · Cited by 7
Malagón-Rojas, J., Rubio, V. V., & Parra-Barrera, E. L. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab006 · Cited by 7
Kim, D., Lee, J., Bal, J., Chong, C., Lee, J. H., & Park, H. K. (2021) · Diagnostics · doi:10.3390/diagnostics11030537 · Cited by 7
Lau, C. S., Hoo, S. P., Yl, L., Phua, S. K., & Aw, T. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00230 · Cited by 7
Seroprevalence of SARS-CoV-2 antibodies in patients with autoimmune inflammatory rheumatic diseases
Eviatar, T., Furer, V., Polachek, A., Levartovsky, D., Elalouf, O., Zisapel, M., Halperin, T., Turner, D., Paran, D., Pel, S., et al. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/ykin5p · Cited by 7
Jeon, D. Y., & Jang, C. (2022) · Liquid Crystals · doi:10.1080/02678292.2022.2028315 · Cited by 7
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Iquitos, Loreto, PeruPreprint
Álvarez-Antonio, C., Meza‐Sánchez, G., Calampa, C., Casanova, W., Carey, C., Alava, F., Rodríguez, H., & Quispe, A. M. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3759629 · Cited by 7
Zhang, K., Tong, W., Wang, X., & Lau, J. Y. (2020) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaa032 · Cited by 6
Self-citationŠušak, B., Mikulić, V., Lazarević, A., Mikulić, I., & Arapović, J. (2021) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.6340 · Cited by 6
A pre-vaccine exploratory survey of SARS-CoV-2 humoral immunity among Egyptian general population
El‐Ghitany, E. M., Farag, S., Farghaly, A. G., Hashish, M. H., Hassaan, M. A., & Omran, E. A. H. (2022) · Tropical Medicine and Health · doi:10.1186/s41182-022-00448-x · Cited by 6
The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development
Hajissa, K., Mussa, A., Karobari, M. I., Abbas, M. A., Ibrahim, I. K., Assiry, A. A., Iqbal, A., Alhumaid, S., Mutair, A. S. A., Rabaan, A. A., et al. (2022) · Vaccines · doi:10.3390/vaccines10081346 · Cited by 7
Okada, Y., Ueda, M., & Nishiura, H. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.107223 · Cited by 6
Significant reduction of humoral response to SARS-CoV-2 4 months after the diagnosis of COVID-19
Zhang, K., Ma, Z., Yang, L., Kang, W., Yin, Y., & Lau, J. Y. (2020) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaa036 · Cited by 8
Self-citationSARS-CoV-2 antibody seroprevalence in NHS healthcare workers in a large double-sited UK hospital
Ken‐Dror, G., Wade, C., Sharma, S. S., Irvin-Sellers, M. J., Robin, J. G., Fluck, D. S., Bentley, P., & Sharma, P. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-1096 · Cited by 6
COVID ‐19 by numbers ‐ infections, cases and deaths
Brüssow, H. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15377 · Cited by 6
Nesbitt, D. J., Jin, D. K., Hogan, J. W., Chan, P. A., Simon, M. J., Vargas, M., King, E., Huard, R. C., Bandy, U., Hillyer, C. D., et al. (2020) · doi:10.21203/rs.3.rs-76664/v1 · Cited by 6
Strugnell, R. A., & Wang, N. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00434-7 · Cited by 5
Carboxylic submetabolome-driven signature characterization of COVID-19 asymptomatic infection
Xu, J., Yuan, Y. L., Chen, Y.-Y., Xiong, C.-F., Zhang, Z., & Feng, Y. (2021) · Talanta · doi:10.1016/j.talanta.2021.123086 · Cited by 5
Pagheh, A. S., Asghari, A., Romenjan, K. A., Mousavi, T., Abedi, F., Ziaee, A., Malakimoghadam, H., & Ziaee, M. (2022) · Iranian Journal of Microbiology · doi:10.18502/ijm.v14i2.9178 · Cited by 4
Sandie, A. B., Sack, F. N., Medi, C. I., Nkodo, J. M. M., Pangetna, H. N., Mimfoumou, H. G. A., Lobe, S. A., Noumbissi, D. C., Mfoubi, F. T., Tagnouokam‐Ngoupo, P. A., et al. (2023) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-023-00102-7 · Cited by 5
Atsawawaranunt, K., Thiangthangthum, K., Sirikhetkon, S., Jampathong, P., Kongklieng, A., Nakphook, S., Phonsingh, P., Yorsaeng, R., Praphasiri, P., & Mungaomklang, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16501 · Cited by 5
Eviatar, T., Elalouf, O., Furer, V., Goldstein‐Lahat, Y., Paran, Y., Pel, S., Nevo, S., Zisapel, M., Alcalay, Y., & Elkayam, O. (2021) · Internal Medicine Journal · doi:10.1111/imj.15202 · Cited by 5
Rafi, A. M., Tomy, M. M. L. J., Thomas, R., Valsan, C., Unnikrishnan, U. G., Innah, S. J., & Kuttichira, P. (2021) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2021/48703.15154 · Cited by 5
Takalay, S., Ngo‐Giang‐Huong, N., Kongnim, W., Mongkolwat, P., Phoseng, P., Wangsaeng, N., Hongjaisee, S., Butr-Indr, B., Tragoolpua, K., Jourdain, G., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263127 · Cited by 5
Lins, I. D., Raupp, L. S., Maior, C. B. S., Felipe, F. C. D. B., Moura, M. J. D. C., Santana, J. M., dos Santos, A., Freitas, M. V. D. A., da Silva, R. N., da Conceição, E. H., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265016 · Cited by 5
Murongazvombo, A. S., Jones, R., Rayment, M., Mughal, N., Azadian, B. S., Donaldson, H., Davies, G., Moore, L. S. P., & Aiken, A. M. (2021) · Infection Prevention in Practice · doi:10.1016/j.infpip.2021.100157 · Cited by 5
Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand
Lerdsamran, H., Mungaomklang, A., Iamsirithaworn, S., Prasertsopon, J., Prasert, K., Intalapaporn, P., Siriyakorn, N., Wiriyarat, W., Thinpan, N., Sawadpongpan, S., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06921-y · Cited by 6
Demirbakan, H., Koçer, İ., Erdoğan, M., & Bayram, A. (2022) · Public Health · doi:10.1016/j.puhe.2022.01.011 · Cited by 5
Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
Peterhoff, D., Wiegrebe, S., Einhauser, S., Patt, A. J., Beileke, S., Günther, F., Steininger, P. A., Niller, H. H., Burkhardt, R., Küchenhoff, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1242536 · Cited by 4
Wang, W., Shi, S., Liu, Y., Hou, Z., Qi, J., & Guo, L. (2023) · Optics Express · doi:10.1364/oe.504640 · Cited by 4
Resetting the Initial Conditions for Calculating Epidemic Spread: COVID-19 Outbreak in Italy
Babac, M. B., & Mornar, V. (2020) · IEEE Access · doi:10.1109/access.2020.3015923 · Cited by 4
Qaseem, A., Yost, J., Etxeandia‐Ikobaltzeta, I., Forciea, M. A., Abraham, G. M., Miller, M. C., Obley, A. J., & Humphrey, L. L. (2021) · Annals of Internal Medicine · doi:10.7326/m20-7569 · Cited by 4
Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients
Łodyga, M., Maciejewska, K., Eder, P., Waszak, K., Stawczyk‐Eder, K., Dobrowolska, A., Kaczka, A., Gąsiorowska, A., Stępień-Wrochna, B., Cicha, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163689 · Cited by 4
Gong, X., Cui, P., Wu, H., Pān, H., Teng, Z., Yuan, F., Mao, S., Kong, D., Han, R., Zhao, X., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07173-0 · Cited by 4
Sočan, M., Prosenc, K., Kukec, A., Zaletel‐Kragelj, L., Remec, T., & Grmek-Košnik, I. (2022) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.01932 · Cited by 4
Jeong, S., Hong, Y. R., & Hwang, H. (2022) · Kosin Medical Journal · doi:10.7180/kmj.22.114 · Cited by 4
Sumpaico-Tanchanco, L., Sy, J. C. Y., Dy, A. B. C., Levantino, M., Amit, A. M. L., Wong, J. Q., Angeles, K., & Vergara, J. P. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268145 · Cited by 4
Chen, Y., Yang, M., Lai, J.-Z., Chen, J.-W., Wang, Y., Wei, S., Hou, S., Chen, C., & Wu, H.-S. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad614 · Cited by 4
COVID-19 seroprevalence study of an Indian Diagnostic Laboratory - Report on gender and age analysis
Kallathiyan, K., Velumani, A., Iyer, S., Sivapandi, K., & Velumani, A. (2020) · Asian Journal of Health Sciences · doi:10.15419/ajhs.v6i2.478 · Cited by 4
He, L., Zeng, Y., Zeng, C., Zhou, Y., Li, Y., Xie, X., Xu, W., Luo, W., Hu, J., Yi, Z., et al. (2020) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2020.691 · Cited by 4
Healthcare worker seroconversion for SARS-CoV-2 at two large health systems in San Diego
Nicholson, L., McLawhon, R. W., Kurian, S. M., Fitzgerald, R. L., Case, J., Marsh, C. L., & Quigley, M. M. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.12.017 · Cited by 4
Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers
Wang, R. C., Murphy, C. E., Kornblith, A. E., Kurtz, T. W., & Kohn, M. A. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.01.010 · Cited by 4
Maeda, T., Kashiwagi, K., Yoshizawa, S., Sato, T., Aoki, K., Ishii, Y., & Tateda, K. (2021) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2020.799 · Cited by 4
Tied Infections: How Social Connectedness to Other COVID-19 Patients Influences Illness Severity
Yan, X., Qu, T., Sperber, N., Lu, J., Fan, M., & Cornwell, B. T. (2021) · American Behavioral Scientist · doi:10.1177/00027642211003138 · Cited by 4
Alasmari, F. A., Mukahal, M., AlQurashi, A., Huq, M. M., Alabdrabalnabi, F., AlJurayyan, A. N., Alkahtani, S. M., Assari, F. S., Bashaweeh, R., Salam, R., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272818 · Cited by 5
Murillo, A. M., Valle, L. G., Ramírez, Y., Naranjo, M. J. S., Santamaría, B., Roldán, E. M., Ortega‐Madueño, I., Urcelay, E., Tramarin, L., Herreros, P., et al. (2022) · Biosensors · doi:10.3390/bios12090671 · Cited by 4
Qaseem, A., Yost, J., Etxeandia‐Ikobaltzeta, I., Forciea, M. A., Abraham, G. M., Miller, M. C., Obley, A. J., Humphrey, L. L., Akl, E. A., Andrews, R., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-3272 · Cited by 4
Ojeda, D. S., Ledesma, M. M. G. L., Pallarés, H. M., Navarro, G. S. C., Sánchez, L., Perazzi, B. E., Villordo, S. M., Alvarez, D. E., BioBanco Working Group, Echavarría, M., et al. (2020) · medRxiv · doi:10.1101/2020.10.21.20216960 · Cited by 4
Mass SARS-CoV-2 serological screening for the Principality of AndorraPreprint
Royo, C., Vilanova, D., López, J., Arroyo, V., Francisco, G., Pons, M., Carrasco, M. G., Piqué, J. M., Sanz, S., Dobaño, C., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-119323/v1 · Cited by 4
Cai, S., Liao, G., Yu, T., Gao, Q., Zou, L., Zhang, H., Xu, X., Chen, J., Lu, A., Wu, Y., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3912536 · Cited by 4
Self-citationLi, S., Qiu, Y., Tang, L., Wang, Z., Cao, W., Zhou, X., & Sun, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.695428 · Cited by 3
Yadav, R. M., Pate, A., Shankarkumar, A., Athalye, S., Shinde, S., Bargir, U. A., Pate, M., Ganpule, M., Pruthi, M., Patil, H. A., et al. (2021) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.210518.001 · Cited by 3
Zhang, Y., Liu, X.-Z., Zhang, Z., Zhou, T., Zhang, X., Yang, H.-Y., Tan, M., Hu, N., Shi, S.-F., Wang, F., et al. (2021) · National Science Review · doi:10.1093/nsr/nwac034 · Cited by 3
Wang, C., Li, Y., Pan, Y., Zhou, L., Zhang, X., Yan, W., Guo, F., Shu, Y., & Gao, J. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200054 · Cited by 3
Massive Pulmonary Embolism in an Adolescent With Multisystem Inflammatory Syndrome Due to COVID-19
Anastas, D. C., Farias, A., Runyon, J., Laufer, M., Sendi, P. R., Totapally, B., & Sachdeva, R. C. (2021) · Clinical Pediatrics · doi:10.1177/00099228211015522 · Cited by 3
Covid-19 Serosurveillance Positivity in General Population: Comparison at Different Times
Prakash, O., Solanki, B., Sheth, J. K., Shah, C., Kadam, M., Vyas, S., Shukla, A. A., & Tiwari, H. (2021) · National Journal of Community Medicine · doi:10.5455/njcm.20210518084014 · Cited by 3
O’Kelly, B., McLaughlin, R. A., O’Doherty, R., Carroll, H. K., Murray, R., Dilworth, R., Corkery, L., Cotter, A. G., McGinty, T., Muldoon, E. G., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.642318 · Cited by 3
Serosurveillance among COVID-19 Cases in Ahmedabad Using SARS-COV2 IgG Antibodies
Prakash, O., Solanki, B., Sheth, J. K., Maitrak, D., Kadam, M., Vyas, S., Shukla, A. A., & Tiwari, H. (2021) · Indian Journal of Community Health · doi:10.47203/ijch.2021.v33i02.022 · Cited by 3
COVID-19 and the Unraveling of Experimental Medicine - Part I
Thorp, K. E., & Thorp, J. A. (2022) · The Gazette of Medical Sciences · doi:10.46766/thegms.pubheal.22012306 · Cited by 3
Puchades, A., Daniel, R., Geen, J., Peden, J., Lewis, H., & Nnoaham, K. E. (2022) · BMC Public Health · doi:10.1186/s12889-021-12478-x · Cited by 3
Clinical Epidemiology of Coronavirus Disease 2019:Defined on Current Research
Zhang, F., & Hughes, C. L. (2020) · Global Clinical and Translational Research · doi:10.36316/gcatr.02.0032 · Cited by 3
SARS-CoV-2 seroprevalence in the Vatican City State
Ralli, M., Arcangeli, A., Soave, P. M., Voglino, M. C., & De‐Giorgio, F. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.01.029 · Cited by 3
Yuan, Y., Wang, H., Zhao, J., Jing, N., Xu, J., Li, W., Ma, B., Zhang, J., Li, G., Wang, S., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.559447 · Cited by 3
SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan
Nishimura, T., Uwamino, Y., Uno, S., Kashimura, S., Shiraki, T., Kurafuji, T., Morita, M., Noguchi, M., Azegami, T., Yamada-Goto, N., et al. (2021) · Internal Medicine · doi:10.2169/internalmedicine.7033-21 · Cited by 3
Big Thunder, Little Rain: The Yellow Peril Framing of the Pandemic Campaign Against China
Sautman, B. (2021) · Chinese Journal of International Law · doi:10.1093/chinesejil/jmab023 · Cited by 3
Prguda-Mujić, J., Hasanić, O., Bešić, L., Ašić, A., Halilović, S., Kulo, A., Ljevakovic, N., Muminovic, F., Huseinovic, S., Ler, D., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265431 · Cited by 4
Fuméry, M., Matias, C., & Brochot, É. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa154 · Cited by 3
Wang, L., Liu, X., Tang, X., & Zhang, H. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0754 · Cited by 2
Antibody Response and Therapy in COVID-19 Patients: Significance in Vaccine DevelopmentPreprint
Lu, L., Zhang, H., Zhan, M., Jiang, J., Yin, H., Dauphars, D. J., Li, S., Li, Y., & He, Y.-W. (2020) · Preprints.org · doi:10.20944/preprints202008.0166.v1 · Cited by 3
Wang, X., Gao, W., Cui, S., Zhang, Y., Zheng, K., Ke, J., Lv, J., Yu, C., Sun, D., Wang, Q., et al. (2020) · Research Square · doi:10.1101/2020.09.23.20197756 · Cited by 3
“The COVID-19 pandemic in BRICS: Milestones, interventions, and molecular epidemiology”
van Wyk, S., Moir, M., Banerjee, A., Bazykin, G. A., Biswas, N. K., Sitharam, N., Das, S., Ma, W., Maitra, A., Mazumder, A., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003023 · Cited by 4
SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala
Davila-Siliezar, P. A., Wer, A., & Barnoya, J. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1993325 · Cited by 2
The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis
Hasan, T., Lim, H. L., Case, J., Hueston, L., Bag, S. K., Dwyer, D. E., & O'Sullivan, M. V. N. (2021) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.13155 · Cited by 2
Levels of antibodies to SARS-CoV-2 at key time points during the COVID-19 pandemic in China
Liu, L., & Hui, L. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1271917 · Cited by 2
Enhanced immunity against SARS-CoV-2 in returning Chinese individuals
Yuan, R., Chen, H., Yi, L., Li, X., Hu, X., Li, X., Zhang, H., Zhou, P., Liang, C., Lin, H., et al. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2300208 · Cited by 4
Self-citationReflections on COVID-19: A Literature Review of SARS-CoV-2 Testing
Lau, C. S., Oh, H. M., & Aw, T. C. (2024) · Vaccines · doi:10.3390/vaccines13010009 · Cited by 2
Guang, Y., Liu, L., & Liu, H. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70184 · Cited by 2
Antibody responses to SARS‐CoV‐2 in healthy individuals returning to Shenzhen
Zhang, C., Lin, L., Tang, D., Liu, F., Li, M., Qiong-ying, L., Deng, Z., Chu, G., Gu, D., & Dai, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26355 · Cited by 2
Magaña‐Guerrero, F. S., Hinojosa‐Trujillo, D., Buentello‐Volante, B., Aguayo-Flores, J. E., Melgoza-González, E. A., Hernández, J., Martínez, M. D. C. J., Pérez‐Tapia, S. M., & Garfias, Y. (2021) · Ophthalmic Epidemiology · doi:10.1080/09286586.2021.1974493 · Cited by 2
Bartko, J., Zehetmayer, S., Weseslindtner, L., Stiasny, K., Schloegl, A., Forjan, E., Zwettler, E., Krauter, A., Keil, F., & Sédille-Mostafaie, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091909 · Cited by 2
Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
Yao, J., Wang, H., Yu, W., Li, Y., Luo, Z., Wu, B., Zhang, W., Liu, X., & Lv, C. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s326740 · Cited by 2
Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19
Haq, M., Rehman, A., Haq, M., Haq, H., Rajab, H., Aḥmad, J., Ahmed, J., Anwar, S., Ahmad, S., & Haq, N. U. (2022) · Therapeutic Advances in Vaccines and Immunotherapy · doi:10.1177/25151355221080724 · Cited by 2
Marchi, S., Lanave, G., Camero, M., Dapporto, F., Manenti, A., Benincasa, L., Acciavatti, A., Brogi, G., Viviani, S., Montomoli, E., et al. (2022) · Viruses · doi:10.3390/v14071441 · Cited by 2
Metadata
- Authors
- Xu, X., Sun, J., Nie, S., Li, H., Kong, Y., Liang, M., Hou, J., Huang, X., Li, D., Ma, T., Peng, J., Gao, S., Shao, Y., Zhu, H., Lau, J. Y.-N., Wang, G., Xie, C., Jiang, L., Huang, A., Yang, Z., Zhang, K., & Hou, F. F.
- Affiliations
- Nanfang Hospital (CN)
- Kingmed Diagnostics (CN)
- First People's Hospital of Foshan (CN)
- Honghu People’s Hospital (CN)
- First People's Hospital of Jingzhou (CN)
- Jingzhou Central Hospital (CN)
- Honghu Hospital of Traditional Chinese Medicine (CN)
- Hong Kong Polytechnic University (HK)
- Tsinghua University (CN)
- University of Electronic Science and Technology of China (CN)
- Chongqing Medical University (CN)
- Macau University of Science and Technology (MO)
- Corresponding author
- Huang, Ailong
- Yang, Zhenglin
- Zhang, Kang
- Hou, Fan Fan
- ORCID
- Venue
- Nature Medicine
- Published
- 2020-06-05
- Volume
- 26
- Issue
- 8
- Pages
- 1193-1195
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W3033219406
- Cited by
- 405
- References
- 14
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 16 · 2023: 28 · 2022: 58 · 2021: 174 · 2020: 118
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-08-18)
- Open access
- bronze
- doi.org
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundo para o Desenvolvimento das Ciências e da Tecnologia (0035/2020/A)
- Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2020GZR110306001, 2018GZR110102004, 2018GZR0201003)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, seroprevalence, immunoglobulin M, IgG, serological surveillance, asymptomatic infection, Wuhan, hemodialysis patients, healthcare workers, regional variation
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Antibodies, Viral, China, Female, Health Personnel, Humans, Immunoglobulin G, Immunoglobulin M, Male, Middle Aged, Pneumonia, Viral, Seroepidemiologic Studies, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
